TELA Bio, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
TELA Bio, Inc. (TELA) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price of $6.41 per share as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice · last filed 2026-08-11
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $6.41.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $6.54.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $8.62.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $8.78.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price |
|---|---|
| 2026-06-30 | $6.41 10-Q · filed 2026-08-11 |
| 2026-03-31 | $6.54 10-Q · filed 2026-05-13 |
| 2025-12-31 | $8.62 10-Q · filed 2026-08-11 |
| 2025-09-30 | $8.78 10-Q · filed 2025-11-14 |
| 2025-06-30 | $8.66 10-Q · filed 2025-08-11 |
| 2025-03-31 | $9.52 10-Q · filed 2025-05-08 |
| 2024-12-31 | $10.92 10-K · filed 2026-03-25 |
| 2024-09-30 | $10.91 10-Q · filed 2024-11-08 |
| 2024-06-30 | $11.07 10-Q · filed 2024-08-13 |
| 2024-03-31 | $11.11 10-Q · filed 2024-05-10 |
| 2023-12-31 | $11.48 10-K · filed 2026-03-25 |
| 2023-09-30 | $11.46 10-Q · filed 2023-11-13 |
| 2023-06-30 | $11.46 10-Q · filed 2023-08-10 |
| 2023-03-31 | $11.44 10-Q · filed 2023-05-11 |
| 2022-12-31 | $11.49 10-K · filed 2026-03-25 |
| 2022-09-30 | $11.57 10-Q · filed 2022-11-10 |
| 2022-06-30 | $11.67 10-Q · filed 2022-08-11 |
| 2022-03-31 | $11.84 10-Q · filed 2022-05-11 |
| 2021-12-31 | $11.88 10-K · filed 2025-03-21 |
| 2021-09-30 | $11.81 10-Q · filed 2021-11-12 |
| 2021-06-30 | $11.57 10-Q · filed 2021-08-12 |
| 2021-03-31 | $11.50 10-Q · filed 2021-05-14 |
| 2020-12-31 | $10.87 10-K · filed 2024-03-22 |
| 2020-09-30 | $10.81 10-Q · filed 2020-11-12 |
| 2020-06-30 | $10.79 10-Q · filed 2020-08-13 |
| 2020-03-31 | $10.61 10-Q · filed 2020-05-15 |
| 2019-12-31 | $10.35 10-K · filed 2023-03-23 |
| 2019-09-30 | $6.07 10-Q · filed 2019-12-18 |
| 2018-12-31 | $5.84 10-K · filed 2022-03-23 |
| 2017-12-31 | $5.81 10-K · filed 2021-03-25 |
| 2016-12-31 | $5.77 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| InspireMD, Inc. (NSPR) | $0.033B |